KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Charles River Laboratories International (CRL) EPS (Basic): 2009-2025

Historic EPS (Basic) for Charles River Laboratories International (CRL) over the last 17 years, with Sep 2025 value amounting to $1.11.

  • Charles River Laboratories International's EPS (Basic) fell 17.16% to $1.11 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.52, marking a year-over-year decrease of 118.88%. This contributed to the annual value of $0.20 for FY2024, which is 97.84% down from last year.
  • Charles River Laboratories International's EPS (Basic) amounted to $1.11 in Q3 2025, which was up 4.72% from $1.06 recorded in Q2 2025.
  • Over the past 5 years, Charles River Laboratories International's EPS (Basic) peaked at $3.69 during Q4 2022, and registered a low of -$4.19 during Q4 2024.
  • For the 3-year period, Charles River Laboratories International's EPS (Basic) averaged around $1.10, with its median value being $1.34 (2024).
  • Its EPS (Basic) has fluctuated over the past 5 years, first skyrocketed by 49.59% in 2022, then crashed by 214.79% in 2024.
  • Over the past 5 years, Charles River Laboratories International's EPS (Basic) (Quarterly) stood at $2.73 in 2021, then spiked by 35.16% to $3.69 in 2022, then decreased by 1.08% to $3.65 in 2023, then plummeted by 214.79% to -$4.19 in 2024, then decreased by 17.16% to $1.11 in 2025.
  • Its EPS (Basic) stands at $1.11 for Q3 2025, versus $1.06 for Q2 2025 and $0.50 for Q1 2025.